Filing Details
- Accession Number:
- 0001520138-15-000167
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-10 18:40:14
- Reporting Period:
- 2015-04-07
- Filing Date:
- 2015-04-10
- Accepted Time:
- 2015-04-10 18:40:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1590695 | Twinlab Consolidated Holdings Inc. | TLCC | Medicinal Chemicals & Botanical Products (2833) | 463951742 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1558432 | Capstone Financial Group, Inc. | 2600 Michelson Drive Suite 700 Irvine CA 92612 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-04-07 | 131,578 | $0.76 | 15,847,741 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2015-04-07 | 394,737 | $0.76 | 16,242,478 | No | 4 | X | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | X | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 | Warrant Series A (right to buy) | Disposition | 2015-04-07 | 394,737 | $0.00 | 394,737 | $0.76 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
51,973,684 | 2014-10-01 | 2017-10-31 | No | 4 | X | Direct |
Footnotes
- In addition, Capstone Financial Group, Inc. exercised third-party call options for at least a further 1,498,500 shares on February 23, 2015, but the optionors of such shares have not yet honored the exercise. When they do, this Form 4 will be amended to reflect the additional shares.